Lyell Immunopharma Inc (LYEL)
0.9478
+0.03
(+3.40%)
USD |
NASDAQ |
Nov 22, 16:00
0.9478
0.00 (0.00%)
After-Hours: 17:59
Lyell Immunopharma Price to Book Value: 0.4987 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 0.4823 |
| November 20, 2024 | 0.5419 |
| November 19, 2024 | 0.584 |
| November 18, 2024 | 0.584 |
| November 15, 2024 | 0.5788 |
| November 14, 2024 | 0.5788 |
| November 13, 2024 | 0.5788 |
| November 12, 2024 | 0.613 |
| November 11, 2024 | 0.6366 |
| November 08, 2024 | 0.6419 |
| November 07, 2024 | 0.6419 |
| November 06, 2024 | 0.7787 |
| November 05, 2024 | 0.6524 |
| November 04, 2024 | 0.614 |
| November 01, 2024 | 0.5415 |
| October 31, 2024 | 0.4643 |
| October 30, 2024 | 0.415 |
| October 29, 2024 | 0.4584 |
| October 28, 2024 | 0.4526 |
| October 25, 2024 | 0.4482 |
| October 24, 2024 | 0.527 |
| October 23, 2024 | 0.556 |
| October 22, 2024 | 0.556 |
| October 21, 2024 | 0.5415 |
| October 18, 2024 | 0.5656 |
| Date | Value |
|---|---|
| October 17, 2024 | 0.5705 |
| October 16, 2024 | 0.6043 |
| October 15, 2024 | 0.5656 |
| October 14, 2024 | 0.5753 |
| October 11, 2024 | 0.5705 |
| October 10, 2024 | 0.527 |
| October 09, 2024 | 0.5221 |
| October 08, 2024 | 0.5463 |
| October 07, 2024 | 0.5463 |
| October 04, 2024 | 0.5898 |
| October 03, 2024 | 0.5753 |
| October 02, 2024 | 0.5946 |
| October 01, 2024 | 0.6188 |
| September 30, 2024 | 0.6672 |
| September 27, 2024 | 0.6824 |
| September 26, 2024 | 0.6869 |
| September 25, 2024 | 0.6101 |
| September 24, 2024 | 0.6598 |
| September 23, 2024 | 0.6462 |
| September 20, 2024 | 0.6824 |
| September 19, 2024 | 0.705 |
| September 18, 2024 | 0.6101 |
| September 17, 2024 | 0.6281 |
| September 16, 2024 | 0.5604 |
| September 13, 2024 | 0.5558 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.415
Minimum
Oct 30 2024
4.205
Maximum
Sep 10 2021
1.380
Average
1.028
Median
May 18 2022
Price to Book Value Benchmarks
| Chimerix Inc | 0.6006 |
| NovaBay Pharmaceuticals Inc | 3.142 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.361 |
| Theriva Biologics Inc | 0.1457 |
Price to Book Value Related Metrics
| PS Ratio | 3831.67 |
| PEG Ratio | -0.3039 |
| Price | 0.9478 |
| Earnings Yield | -83.35% |
| Market Cap | 264.65M |
| PEGY Ratio | -0.3039 |